anmelden
Stoxx Europe 50
5.082,32
PKT
+46,66
PKT
+0,93
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.02.22 | Roche Buy | Deutsche Bank AG | |
| 07.02.22 | Novo Nordisk Hold | Deutsche Bank AG | |
| 07.02.22 | BP Sector Perform | RBC Capital Markets | |
| 07.02.22 | Intesa Sanpaolo Buy | Deutsche Bank AG | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.02.22 | Sanofi Outperform | Credit Suisse Group | |
| 07.02.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 07.02.22 | Intesa Sanpaolo Buy | UBS AG | |
| 07.02.22 | ING Group Buy | UBS AG | |
| 07.02.22 | Intesa Sanpaolo Neutral | Credit Suisse Group | |
| 07.02.22 | VINCI Buy | Goldman Sachs Group Inc. | |
| 07.02.22 | Deutsche Telekom Buy | Jefferies & Company Inc. | |
| 07.02.22 | BBVA Outperform | RBC Capital Markets | |
| 07.02.22 | Roche Overweight | Barclays Capital | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 07.02.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 07.02.22 | VINCI Overweight | JP Morgan Chase & Co. | |
| 07.02.22 | Santander Overweight | Barclays Capital | |
| 07.02.22 | Intesa Sanpaolo Overweight | Barclays Capital | |
| 07.02.22 | Deutsche Telekom Overweight | Barclays Capital | |
| 07.02.22 | Allianz Neutral | JP Morgan Chase & Co. | |
| 07.02.22 | Münchener Rückversicherungs-Gesellschaft Overweight | JP Morgan Chase & Co. | |
| 05.02.22 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 05.02.22 | Santander Sector Perform | RBC Capital Markets | |
| 04.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.22 | Intesa Sanpaolo Hold | Jefferies & Company Inc. | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 04.02.22 | ING Group Underweight | Barclays Capital | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.02.22 | Roche Overweight | Barclays Capital | |
| 04.02.22 | BBVA Neutral | UBS AG | |
| 04.02.22 | Roche Neutral | UBS AG | |
| 04.02.22 | Nestlé Buy | UBS AG | |
| 04.02.22 | Enel Buy | UBS AG | |
| 04.02.22 | Sanofi Buy | UBS AG | |
| 04.02.22 | VINCI Buy | UBS AG | |
| 04.02.22 | BBVA Equal Weight | Barclays Capital | |
| 04.02.22 | Sanofi Outperform | Bernstein Research |